by Sagarika Sharma | Mar 17, 2022 | OTC Drugs, U.S. Regulatory
On March 14, 2022, the U.S Food and Drug Administration (FDA) has announced the rates for over the counter (OTC) monograph drug user fees for fiscal year (FY) 2022 in a Federal Register Notice (FRN) titled ‘Over-The-Counter Monograph Drug User Fee Rates for FY 2022”....
by Sagarika Sharma | Mar 17, 2022 | Canadian Regulatory, Cosmetics, Natural Health Products, OTC Drugs, Research/Science/Technology
The Department of the Environment published a notice on March 12, 2022 to collect information on the commercial status and use of approximately 700 substances including biopolymers, plant extracts, mineral extracts, proteins, fats, animal extracts, waxes and...
Recent Comments